Part 4A Fees for consultation in relation to the safety, quality and usefulness of a medicinal substance incorporated in a deviceF1
- 19AInterpretation of Part 4A
- 19BCircumstances in which a fee is payable in relation to a consultation on the safety, quality and usefulness of a medicinal substance incorporated in a device
- 19CFees payable in connection with a consultation or further consultation on the safety, quality and usefulness of a medicinal substance incorporated in a device
- 19DFees for pre-consultation meetings
Annotations
Textual amendments
- F1
Pt. 4A inserted (1.4.2023) by The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023 (S.I. 2023/377), regs. 1(2), 23